Literature DB >> 8941381

Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909.

J R Glowa1, W E Fantegrossi, D B Lewis, D Matecka, K C Rice, R B Rothman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8941381     DOI： 10.1021/jm960551t

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  17 in total

1.  Rebound hypersomnolence, stimulant abuse, and DAT-mediated dopamine release.

Authors:  Seiji Nishino
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

2.  Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeys.

Authors:  Gail Pereira Do Carmo; Nancy K Mello; Kenner C Rice; John E Folk; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2006-07-05       Impact factor: 4.432

3.  Further structure-activity relationship studies on 8-substituted-3-[2-(diarylmethoxyethylidenyl)]-8-azabicyclo[3.2.1]octane derivatives at monoamine transporters.

Authors:  Shaine A Cararas; Sari Izenwasser; Dean Wade; Amy Housman; Abha Verma; Stacey A Lomenzo; Mark L Trudell
Journal:  Bioorg Med Chem       Date:  2011-10-18       Impact factor: 3.641

4.  CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.

Authors:  Zheng-Xiong Xi; Rui Song; Xia Li; Guan-Yi Lu; Xiao-Qing Peng; Yi He; Guo-Hua Bi; Siyuan Peter Sheng; Hong-Ju Yang; Haiying Zhang; Jin Li; Mark Froimowitz; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

Review 5.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

6.  Daily monitoring of dopamine efflux reveals a short-lasting occlusion of the dopamine agonist properties of d-amphetamine by dopamine transporter blockers GBR 12909 and methylphenidate.

Authors:  Soyon Ahn; Anthony G Phillips
Journal:  ACS Chem Neurosci       Date:  2013-05-03       Impact factor: 4.418

7.  Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys.

Authors:  Joshua A Lile; Drake Morgan; Anne M Birmingham; Huw M L Davies; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

Review 8.  Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.

Authors:  Richard B Rothman; Michael H Baumann; Thomas E Prisinzano; Amy Hauck Newman
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

Review 9.  Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Authors:  Zheng-Xiong Xi; Eliot L Gardner
Journal:  Curr Drug Abuse Rev       Date:  2008-11

Review 10.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.